These compounds may interact with:

Phosphomannomutase 2

Potentially involved in: congenital disorder of glycosylation; digeorge syndrome; multiple congenital anomalies-hypotonia-seizures syndrome 3; galactosemia; hereditary fructose intolerance syndrome; intellectual disability; cerebellar ataxia; contracture; contracture of joint; diarrhea; epilepsy; esotropia; factor xi deficiency; hepatomegaly; hypothyroidism; cystic kidney; kyphosis deformity of spine; muscle hypotonia; nephrotic syndrome; nystagmus

Disease data sourced from Pharos.